Sign In
Free Newsletter
BioNJ unveils roadmap to boost NJ life sciences leadership
BioNJ released a white paper outlining an eight-year strategy to enhance New Jersey's life sciences sector by elevating its profile, strengthening startups, attracting talent, boosting manufacturing and expanding into adjacent sectors.
Bristol Myers Squibb discloses 247 more layoffs in NJ (updated)
The Lawrenceville-based pharmaceutical giant will eliminate 247 positions in New Jersey as part of a $2B cost-cutting plan tied to a restructuring initiative.
Johnson & Johnson invests $1B in Pennsylvania cell therapy facility
The New Brunswick-based health care giant will build a next-generation cell therapy manufacturing facility in the Keystone State's Montgomery County, supported by $41.5 million from the state.
BioNJ elects Genmab’s Cozic as 2026 board chair
Genmab Executive Vice President Christopher Cozic will serve as chair, following his unanimous election during the life sciences association's annual meeting in East Brunswick.
BioNJ dinner honors life sciences leaders, Sherrill keynotes
Gov. Mikie Sherrill delivered the keynote at the annual event, which highlighted awards, breakthroughs and industry innovators.
Tonix opens Berkeley Heights HQ, expands NJ biotech footprint
The pharmaceutical firm unveiled its headquarters at The Park as it grows its New Jersey biotech footprint following FDA approval of fibromyalgia drug Tonmya.
Choose New Jersey rolls out relocation concierge with BDV
Partnering with BDV Solutions, the first-in-the-nation effort will help companies and global talent settle in the Garden State.
NJ vocational school partnerships fuel health care, life sciences jobs
New Jersey vocational schools are partnering with health care and life sciences employers to build a skilled workforce pipeline.
NJBIZ Looking Ahead 2026: Biggest business opportunities
New Jersey business leaders share where they see the biggest opportunities in 2026, from AI and life sciences to real estate and tourism.
Novartis advances $23B US manufacturing plan in Florida
The new, $70 million radioligand therapy facility is part of the company's $23 billion plan to expand domestic drug production.
OPINION: How New Jersey is leading AI innovation in life sciences
The Garden State is emerging as a national pioneer in artificial intelligence-driven advances in the field, transforming health care, drug discovery and biomanufacturing.
NJEDA approves $12.5M for medtech, maternal health hubs
The funding approved by the New Jersey Economic Development Authority will help support two Strategic Innovation Centers focused on medical technology and maternal and infant health statewide.
